基於V模型、醫療器材標準和FDA指南的新醫療器材軟體開發流程:以ADHD虛擬實境教室為例

以作者查詢圖書館館藏

、以作者查詢臺灣博碩士

、以作者查詢全國書目

、勘誤回報

、線上人數：12

、訪客IP：18.119.131.72

姓名

葉智竣(Chih-Chun Yeh) 查詢紙本館藏

畢業系所

資訊工程學系

論文名稱

基於V模型、醫療器材標準和FDA指南的新醫療器材軟體開發流程:以ADHD虛擬實境教室為例
(New Software as Medical Device Development Process Based on V－Model， Medical Device Standards， and FDA Guidance Example of ADHD VR Classroom)

相關論文

★ 從EEG解釋虛擬實境的干擾對注意力的影響	★ 使用虛擬教室遊戲的基於融合的深度學習注意缺陷多動障礙評估方法
★ 利用分層共現網絡評估發展遲緩兒童的精細運動	★ 太極大師：基於太極拳的注意力訓練遊戲，使用動作辨識及平衡分析進行表現評估
★ 比較XRSPACE MANOVA中手勢和控制器互動模式的用戶體驗	★ 基於骨架步態藉由機器學習進行臨床老化衰落分類
★ 用於注意力不足過動症診斷的可解釋多模態融合模型	★ 基於深度學習的虛擬現實腦震盪檢測與融合方法
★ 在虛擬現實場景中利用多種生理資料進行高壓駕駛的壓力識別

檔案

[Endnote RIS 格式]

[Bibtex 格式]

[相關文章]

[文章引用]

[完整記錄]

[館藏目錄]

至系統瀏覽論文 (2028-6-20以後開放)

摘要(中)

數位治療是一種新興的治療方式，因此醫療器材軟體（SaMD）的使用已變得普遍。然而，軟體缺陷的問題仍未得到解決。為了確保軟體的有效性，各種監管機構已經制定了規定。為了解決這個問題，我們開發了一種新的軟體開發流程，結合了V模型、醫療器材標準，以及美國食品藥品監督管理局對醫療器材內含軟體的上市申請內容指南（2021）。我們在ADHD虛擬現實教室的數位治療中的驗證了這個新流程可行性。研究結果顯示，開發流程確保品質滿足FDA的要求。此流程也有效地管理了從需求分析到最終軟體釋出的各個軟體開發階段。這個流程為未來醫療器材軟體開發的標準提供了基礎。

摘要(英)

Digital therapeutics is an emerging treatment method. Thus, medical as device software (SaMD) has become widely used. However, the issue of software defects is to be solved yet. To ensure the effectiveness of the software, various regulatory agencies have established regulations. To solve this issue, we developed a new software development process combining the V-model, medical device standards standard, and FDA Guidance for the Content of Premarket Submission for Software Contained in Medical Devices (2021). We verified the feasibility of the new process for digital therapy in the ADHD VR Classroom. The research results showed that the developed process ensured its quality to meet the FDA′s requirements. The process effectively manages the various stages of software development from requirementanalysis to the final software release. This process provides the basis as a standard for future medical device software development.

關鍵字(中)

★ 醫療器材軟體
★ 醫療器材標準
★ 美國食品藥品監督管理局
★ V模型
★ 注意力缺失過動症
★ 數位治療

關鍵字(英)

★ software as a medical device (SaMD)
★ medical device standards
★ fda
★ v-model
★ attention deficit hyperactivity disorder
★ digital therapeutics

論文目次

摘要ix
Abstract xi
誌謝xiii
目錄xv
圖目錄xvii
表目錄xix
使用符號與定義xxi
一、Introduction 1
二、Related work 7
2.0.1 ADHD digital therapeutics 7
2.0.2 Software process combined ISO/IEC standards 9
2.0.3 Enhanced V-model for medical devices 10
三、Proposed software development process 13
四、CASE STUDY:ADHD VR Classroom 19
4.0.1 Medical Research and design 19
4.0.2 Quality Management 20
4.0.3 Level evaluation analysis 20
4.0.4 Device hazard analysis 21
4.0.5 Requirements Analysis 23
4.0.6 Risk Analysis 24
4.0.7 Architecture Design and Detail Design 26
4.0.8 Traceability Analysis 30
4.0.9 Testing and Review 31
五、Discussion 35
六、Conclusion 39
參考文獻41

參考文獻

[1] J. S. Hong, C. Wasden, and D. H. Han, ”Introduction of digital therapeutics,” Computer
Methods and Programs in Biomedicine, vol. 209, p. 106319, 2021.
[2] A. Dang, D. Arora, and P. Rane, ”Role of digital therapeutics and the changing
future of healthcare,” Journal of Family Medicine and Primary Care, vol. 9, no. 5,
pp. 2207, 2020.
[3] S.-C. Yeh et al., ”A virtual-reality system integrated with Neuro-behavior sensing for
attention-deficit/hyperactivity disorder intelligent assessment,” IEEE Transactions
on Neural Systems and Rehabilitation Engineering, vol. 28, no. 9, pp. 1899-1907,
2020.
[4] E. J. S. Sonuga-Barke et al., ”Nonpharmacological interventions for ADHD: systematic
review and meta-analyses of randomized controlled trials of dietary and psychological
treatments,” American Journal of Psychiatry, vol. 170, no. 3, pp. 275-289,
2013.
[5] P. S. Jensen, D. Martin, and D. P. Cantwell, ”Comorbidity in ADHD: Implications
for research, practice, and DSM-V,” Journal of the American Academy of Child &
Adolescent Psychiatry, vol. 36, no. 8, pp. 1065-1079, 1997.
[6] Center for Devices and Radiological Health, ”Content of Premarket Submissions
for Device Software Functions,” U.S. Food and Drug Administration, FDA, Nov.
2021. [Online]. Available: https://www.fda.gov/regulatory-information/search-fdaguidance-
documents/content-premarket-submissions-device-software-functions. [Accessed:
May. 3, 2023].
[7] A. A. Khan et al., ”An enhanced agile-V model for system engineering in complex
medical device development,” in 2022 2nd International Conference on Digital Futures
and Transformative Technologies (ICoDT2), IEEE, 2022, pp. 1-6.
[8] M. McHugh, F. McCaffery, and V. Casey, ”Barriers to adopting agile practices when
developing medical device software,” in International Conference on Software Process
Improvement and Capability Determination, Springer, Berlin, Heidelberg, 2012, pp.
141-147.
[9] V. Chandra, ”Comparison between various software development methodologies,”
International Journal of Computer Applications, vol. 131, no. 9, pp. 7-10, 2015.
[10] S. Balaji and M. Sundararajan Murugaian, ”Waterfall vs. V-Model vs. Agile: A
comparative study on SDLC,” International Journal of Information Technology and
Business Management, vol. 2, no. 1, pp. 26-30, 2012.
[11] ISO, ISO 13485:2016 Medical Devices - Quality Management Systems - Requirements
for Regulatory Purposes, 2016.
[12] ISO 14971:2019 Medical devices —Application of risk management to medical devices.
[13] IEC 62304:2006 + AMD1:2015 Medical device software - Software life cycle processes.
[14] S. Balaji and M. Sundararajan Murugaian, ”Waterfall vs. V-Model vs. Agile: A
comparative study on SDLC,” International Journal of Information Technology and
Business Management, vol. 2, no.1, pp. 26-30, 2012.
[15] R. R. J. Jardim et al., ”Integration of the waterfall model with ISO/IEC/IEEE
29148: 2018 for the development of military defense system,” IEEE Latin America
Transactions, vol. 18, no. 12, pp. 2096-2103, 2020.
[16] A. Alshamrani and A. Bahattab, ”A comparison between three SDLC models waterfall
model, spiral model, and Incremental/Iterative model,” International Journal
of Computer Science Issues (IJCSI), vol. 12, no. 1, pp. 106, 2015.
[17] G. Cicotti, ”An evidence-based risk-oriented V-model methodology to develop ambient
intelligent medical software,” Journal of Reliable Intelligent Environments, vol.
3, no. 1, pp. 41-53, 2017.
[18] S. A. Safren, ”Cognitive-behavioral approaches to ADHD treatment in adulthood,”
Journal of clinical Psychiatry, vol. 67, pp. 46, 2006.
[19] L. Castle et al., ”Trends in medication treatment for ADHD,” Journal of attention
disorders, vol. 10, no. 4, pp. 335-342, 2007.
[20] P. S. Jensen et al., ”Cost-effectiveness of ADHD treatments: findings from the multimodal
treatment study of children with ADHD,” American Journal of Psychiatry,
vol. 162, no. 9, pp. 1628-1636, 2005.
[21] S. H. Kollins et al., ”A novel digital intervention for actively reducing severity of paediatric
ADHD (STARS-ADHD): a randomised controlled trial,” The Lancet Digital
Health, vol. 2, no. 4, pp. e168-e178, 2020.
[22] B. E. Yerys et al., ”Brief report: Pilot study of a novel interactive digital treatment to
improve cognitive control in children with autism spectrum disorder and co-occurring
ADHD symptoms,” Journal of autism and developmental disorders, vol. 49, no. 4,
pp. 1727-1737, 2019.
[23] Software as a Medical Device (SaMD): Clinical Evaluation,” Guidance for Industry
and Food and Drug Administration Staff, Document issued on December 8, 2017.
[24] G. Pang et al., ”CoboSkin: Soft robot skin with variable stiffness for safer human–
robot collaboration,” IEEE Transactions on Industrial Electronics, vol. 68, no. 4, pp.
3303-3314, 2020.
[25] C.-C. Yeh, Y.-H. Horng, J. J.-R. Wu, S.-C. Yeh, and E. H.-K. Wu, ”A New Software
as Medical Device Development Process Based on the V-Model, Medical Device
Standards and FDA Guidance: An Example with ADHD VR Classroom,” in 3rd
IEEE International Conference on Electronic Communications, Internet of Things
and Big Data (IEEE ICEIB), 2023 (in press)

指導教授

葉士青吳曉光(Shih-Ching Yeh Hsiao-Kuang Wu)

審核日期

2023-7-24

推文